4 ms·
Hydroxychloroquine in Covid-19: an open-label, randomized, controlled trial
- arkades 6y agoTLDR: Some alleviation of symptom severity in patients not receiving antivirals, overall no real outcome benefit, way more adverse effects. Not a slam-dunk in either direction.